ELI LILLY & Co (LLY) bonds
LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 19/3025% above fair value
$1415.55−16.12 (-1.13%)
Close on Nov 17, 2026Market cap $1.33TP/E 45.9Yield 0.44%
Debt
Borrowings on the balance sheet, Sep 30, 2026
Total debt
$49.50B
$2.52B due within a year
Net debt
$44.62B
After $4.89B of cash
Implied interest rate
2.35%
FY2025 interest ÷ average debt
Interest coverage
–
FY2025 operating income ÷ interest
Total debt by fiscal year
Long-term plus current debt, USD
When the debt comes due
Principal repayments of long-term debt by fiscal year, as scheduled at Dec 31, 2024
From the debt maturity table in the annual report (filing). “Later” is everything due after year five.
Notes and loans outstanding
As tagged in Eli Lilly's 10-Q for the period ended Sep 30, 2026
| Issue | Matures | Carrying value |
|---|---|---|
| Notes due 2026 | 2026 | $1.63B |
| Notes due 2027 | 2027 | $2.52B |
| Notes due 2028 | 2028 | $3.26B |
| Notes due 2029 | 2029 | $3.08B |
| Notes due 2030 | 2030 | $2.13B |
| Notes due 2031 - 2040 | 2031 | $11.58B |
| Notes due 2041 - 2050 | 2041 | $4.54B |
| Notes due 2051 - 2060 | 2051 | $8.28B |
| Notes due 2061 - 2070 | 2061 | $5.82B |
| August 2024 Issuance Date Debt | – | $5.00B |
| August 2025 Issuance Date Debt | – | $6.75B |
| February 2023 Issuance Date Debt | – | $4.00B |
| February 2024 Issuance Date Debt | – | $6.50B |
| February 2025 Issuance Date Debt | – | $6.50B |
| May 2026 | – | $9.00B |
Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.
See a number that looks wrong?